Figure 6From: Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands Price differential for the quadrivalent vaccine to be as cost-effective as the bivalent vaccine. Blue squares indicate the price differential considering the life-years gained and red dots indicate the same if quality-adjusted life years gained are considered.Back to article page